Clocking in: chronobiology in rheumatoid arthritis (Q38387724)

2 September 2017

1 reference

title

Clocking in: chronobiology in rheumatoid arthritis (English)

1 reference

2 September 2017

0 references

1 reference

1

Frank Buttgereit

0 references

Andrew N. Coogan

object named as

Andrew N Coogan

series ordinal

3

0 references

Josef S Smolen

series ordinal

2

object named as

Josef S Smolen

1 reference

2 September 2017

4

Christian Cajochen

1 reference

2 September 2017

language of work or name

English

0 references

publication date

24 March 2015

1 reference

Nature Reviews Rheumatology

2 September 2017

published in

1 reference

2 September 2017

volume

11

1 reference

2 September 2017

issue

6

1 reference

2 September 2017

page(s)

349-356

1 reference

Chronopharmacology: new insights and therapeutic implications

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Mass spectrometry-based discovery of circadian peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Health consequences of circadian disruption in humans and animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

The Colin S. Pittendrigh Lecture. Colin Pittendrigh, Jürgen Aschoff, and the natural entrainment of circadian systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Strange vision: ganglion cells as circadian photoreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Processing of daily and seasonal light information in the mammalian circadian clock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Role of melatonin in the regulation of human circadian rhythms and sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Melatonin: a pleiotropic molecule regulating inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Circadian rhythm of adrenal glucocorticoid: its regulation and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Timing to perfection: the biology of central and peripheral circadian clocks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Molecular components of the Mammalian circadian clock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Transcriptional architecture and chromatin landscape of the core circadian clock in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

A circadian gene expression atlas in mammals: implications for biology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Impact of circadian nuclear receptor REV-ERBα on midbrain dopamine production and mood regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

The nuclear receptor Rev-erbα controls circadian thermogenic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

The rhythm of rest and excess

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Links between Circadian Rhythms and Psychiatric Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Circadian patterns of gene expression in the human brain and disruption in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Phase advance is an actimetric correlate of antidepressant response to sleep deprivation and light therapy in bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Rapid treatment response of suicidal symptoms to lithium, sleep deprivation, and light therapy (chronotherapeutics) in drug-resistant bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

The circadian basis of winter depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

The role of the circadian clock in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Rheumatoid arthritis and the biological clock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Is shift work a risk factor for rheumatoid arthritis? The Finnish Public Sector study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Effect of Shiftwork on Systemic Markers of Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

The pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Exogenous and endogenous glucocorticoids in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Circadian rhythm in pain, stiffness, and manual dexterity in rheumatoid arthritis: relation between discomfort and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Circadian timekeeping is disturbed in rheumatoid arthritis at molecular level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Overnight variations in cortisol, interleukin 6, tumour necrosis factor alpha and other cytokines in people with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Circadian rhythm of serum interleukin-6 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Melatonin serum levels in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

The pineal hormone melatonin exaggerates development of collagen-induced arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Mammalian clock gene Cryptochrome regulates arthritis via proinflammatory cytokine TNF-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Core circadian protein CLOCK is a positive regulator of NF-κB-mediated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

An epithelial circadian clock controls pulmonary inflammation and glucocorticoid action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Dysregulation of inflammatory responses by chronic circadian disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Circadian clocks in mouse and human CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Circadian gene Bmal1 regulates diurnal oscillations of Ly6C(hi) inflammatory monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Treating rheumatoid arthritis to target: recommendations of an international task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Methotrexate chronotherapy is effective against rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

The timing of glucocorticoid administration in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Circadian rhythms of nocturnal hormones in rheumatoid arthritis: translation from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

A simple model that suggests possible cost savings when modified-release prednisone 5 mg/day is added to current treatment in patients with active rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Antidepressant use among persons with recent-onset rheumatoid arthritis: a nationwide register-based study in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Comparative quality of life in patients with depression and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Depression and inflammation: an intricate relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Lipopolysaccharide-induced sepsis induces long-lasting affective changes in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Synergistic effects of celecoxib and bupropion in a model of chronic inflammation-related depression in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

A phase-specific neuroimmune model of clinical depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Neuroinflammation and comorbidity of pain and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Anti-tumor necrosis factor-alpha therapy is associated with less frequent mood and anxiety disorders in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Sleep and rheumatologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Sleep problems in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Sleep, memory and emotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

The contribution of pain and depression to self-reported sleep disturbance in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Circadian rhythm reprogramming during lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Reprogramming of the circadian clock by nutritional challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Identification and validation of cryptochrome inhibitors that modulate the molecular circadian clock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Comparative effectiveness research: a report from the Institute of Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Cancer chronotherapeutics: experimental, theoretical, and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Timing optimizes sustained-release indomethacin treatment of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.31

Rheumatoid arthritis: circadian rhythms in disease activity, signs and symptoms, and rationale for chronotherapy with corticosteroids and other medications.

31 March 2020

1 reference

12 December 2020

Cost-effectiveness of modified-release prednisone in the treatment of moderate to severe rheumatoid arthritis with morning stiffness based on directly elicited public preference values

1 reference

12 December 2020

A description of patient- and rheumatologist-reported depression symptoms in an American rheumatoid arthritis registry population

1 reference

12 December 2020

Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of day

1 reference

12 December 2020

Circadian rhythms - from genes to physiology and disease

1 reference

12 December 2020

Circadian rhythms of cellular immunity in rheumatoid arthritis: a hypothesis-generating study.

1 reference

12 December 2020

Cost-of-illness of rheumatoid arthritis and ankylosing spondylitis

1 reference

12 December 2020

Efficacy of the switch to modified-release prednisone in rheumatoid arthritis patients treated with standard glucocorticoids

1 reference

12 December 2020

Actigraphic measurements of sleep in rheumatoid arthritis: comparison of patients with low back pain and healthy controls

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2015.31

1 reference

Dimensions Publication ID

2 September 2017

1009001346

0 references

1 reference